DOCSLIB.ORG

Effects of Deoxyadenosine Triphosphate

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Effects of Deoxyadenosine Triphosphate [CANCER RESEARCH 40. 3555-3558. October 1980] 0008-5472/80/0040-OOOOS02.00 Effects of Deoxyadenosine Triphosphate and 9-/?-D-Arabinofuranosyl- adenine S'-Triphosphate on Human Ribonucleotide Reducíasefrom Molt-4F Cells and the Concept of "Self-Potentiation"1 Chi-Hsiung Chang2 and Yung-Chi Cheng3 Department of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill. North Carolina 27514 ABSTRACT conceivable that the intracellular activity of this enzyme is influenced or even regulated by the balance of the steady-state Deoxyadenosine triphosphate (dATP) acted as a noncom level of various nucleotides. That is, changes in pool sizes of petitive inhibitor with respect to the specific nucleoside tri nucleotides could influence the reduction of different ribonu- phosphate activator for the reduction of all four common ribo- cleoside diphosphates and result in changes in deoxyribonu- nucleoside diphosphates catalyzed by the reductase derived cleotide levels. Among the nucleotides examined, ATP acted from human Molt-4F (T-type lymphoblast) cells. The inhibition either as an activator for pyrimidine ribonucleoside diphos constant of dATP for different ribonucleotide reduction reac phate reduction or as an accessory activator for purine ribo tions was different, indicating that the binding of the nucleoside nucleoside diphosphate reduction. dATP is the only nucleotide triphosphate activator or substrate could modify the binding which inhibits reduction of all 4 natural ribonucleotides. The affinity of dATP to the enzyme. dATP also acted as a noncom Ki's (obtained by the replots of intercepts and slopes versus petitive inhibitor with respect to cytidine diphosphate (CDP) for inhibitors) were reported previously (4), but the detailed exper reductase-catalyzed CDP reduction. 9-/8-D-Arabinofuranosyl- adenine S'-triphosphate acted as a competitive inhibitor with imental results were not reported; these are included in this paper. It should be noted that the regulation of the enzyme respect to either adenosine triphosphate or guanosine triphos derived from Molt-4F cells is similar to that of the enzymes from phate for CDP or for adenosine diphosphate reduction, respec various sources such as Escherichia coli (9, 10) or other tively. The inhibition constant was 15 /¿MforCDP reduction and mammalian cells (12-14). However, they do differ in their 4 ¡IMfor adenosine diphosphate reduction. 1-/8-o-Arabinofu- ranosyladenine S'-triphosphate could not substitute for aden kinetic properties. Since 9-/?-D-arabinofuranosyladenine exerts cytotoxic ef osine triphosphate or guanosine triphosphate as the activator fects after its conversion to a nucleotide, the effect of ara-ATP4 for CDP or adenosine diphosphate reduction, respectively. The effects of 9-ß-D-arabinofuranosylcytosine 5'-triphosphate and on this enzyme is important for a better understanding of its action. The effects of ara-ATP and ara-CTP on a crude prepa 5-iodo-2'-deoxyuridine 5'-triphosphate on ribonucleotide re ductase were also included for comparison. The "self-potentia- ration of rat tumor ribonucleotide reductase were examined by Moore and Cohen (11 ). It was concluded that ara-ATP inhibited tion" mechanism of the action of 9-ß-D-arabinofuranosylade- nine and 5-iodo-2'-deoxyuridine is discussed. the reduction of all 4 common diphosphate ribonucleotides to about the same extent; inhibition appeared to be similar to that produced by dATP at a lower concentration. ara-CTP was a INTRODUCTION weak inhibitor of this enzyme activity (11 ). Since the purity and source of the enzyme that we studied are different, the effects Ribonucleotide reductase is one of the key enzymes respon of ara-ATP on the partially purified ribonucleotide reductase sible for the synthesis of deoxyribonucleotides which are re from human Molt-4F cells were examined in detail, and the quired for DMA synthesis. Therefore, this enzyme could be effects of ara-CTP and IdUTP on this enzyme are included for considered a target for anticancer agents. The activity of this comparison. enzyme in cells could also influence the cytotoxic effects of certain antitumor agents such as 1-/?-D-arabmofuranosylcyto- sine, 1-/?-D-arabinofuranosyladenine, 5-iodo-2'-deoxyuridine, MATERIALS AND METHODS and 5-fluoro-2'-deoxyuridine. Thus, it is of importance to un Materials. Nucleoside di- and triphosphates (sodium salts), derstand the kinetic behavior of this enzyme. DTT, and 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid We have partially purified ribonucleotide reductase from a were purchased from Sigma Chemical Company, St. Louis, human T-type lymphoblast tumor line (Molt-4F) (2). The kinetic Mo. ara-ATP, IdUTP, and ara-CTP were purchased from P-L behavior of this enzyme in utilizing ADP, GDP, CDP, and UDP Biochemicals, Inc., Milwaukee, Wis. Ammonium salts of all '"C- as substrates indicated that the enzyme can be regulated by labeled nucleotides were supplied by Amersham/Searle Corp., natural nucleoside triphosphates or diphosphates (3, 4). It is Arlington Heights, III. Dowex-1 CI was obtained from Bio-Rad Laboratories, Richmond, Calif. Materials required for cell cul ' This work was supported by USPHS Project Grant CA-27449 from the tures were purchased from Grand Island Biological Co., Grand National Cancer Institute. NIH. This is Paper 5 in a series on human ribonucleotide reductase from Molt-4F cells. Island, N. Y. All other chemicals were of reagent grade. 2 Present address: Biochemistry Department. Southern Research Institute. 2000 Ninth Avenue South, Birmingham, Ala. 35205. 3 An American Leukemia Society Scholar. To whom requests for reprint should " The abbreviations used are: ara-ATP. 9-/i-D-arabinofuranosyladenine 5'- be addressed. triphosphate; ara-CTP. 9-/i-D-arabinofuranosylcytosine 5'-triphosphate; IdUTP. Received February 4. 1980; accepted July 9. 1980. 5-iodo-2'-deoxyuridine S'-triphosphate; DTT. dithiothreitol. OCTOBER 1980 3555 Downloaded from cancerres.aacrjournals.org on September 23, 2021. © 1980 American Association for Cancer Research. C-H. Chang and Y-C. Cheng Preparation of the Enzyme Components. The methods for (A) culturing Molt-4F cells and the purification of Components A \fu 50 ntercept and B of this ribonucleotide redactase have been described (x-x) 30 previously (2). The final preparations of Components A and B are not homogeneous as judged by electrophoretic techniques. However, they were purified to such an extent that nucleotide phosphatase and nucleoside diphosphate kinases, which would interfere with kinetic studies of the enzyme, were not present in the purified Components A and B. All of the studies reported here were performed using the reconstituted enzyme from highly purified components. 05 LO I5 2.0 Enzyme Assays. CDP reducíasewas assayed by the method ATPJ , mMJ of Steeper and Steuart (15) with the use of Dowex 1-borate ion-exchange chromatography. Under "standard conditions," l/v I Slope Intercept 5O the assay mixture contained, in a final volume of 0.2 ml, (x-x) [14C]CDP (0.2 /iCi; 0.15 ITIM),DTT (3 mvi), MgCI2 (6 rriM), ATP (5 rriM), and a specific amount of the enzyme. ADP reductase dATP.uM -50 -30 -IO IO 30 50 activity was determined by the method of Cory et al. (6). Under 50 dATP, uM standard conditions, the assay mixture contained, in a final volume of 0.2 ml, [14C]ADP (0.4 jnCi; 0.3 rriM), DTT (3 ITIM), MgCI2 (6 ITIM), dGTP (5 HIM), and a specific amount of the 20 40 60 enzyme. UDP and GDP reductase activities were determined CDPJ,mM-1 by the method reported previously (3). Under standard condi tions, the assay mixture contained, in a final volume of 0.2 ml, [14C]UDP (0.2 /iCi; 0.15 rriM) or [14C]GDP (0.2 ¿iCi;0.15 mw), Chart 1. Effects of dATP on the Lineweaver-Burk plots of the reciprocal of DTT (3 rriM), MgCI2 (6 rriM), ATP (5 ITIM)for UDP reduction or activator concentration (A) or substrate concentration (B) with respect to the dTTP (5 rriM) for GDP reduction, and a specific amount of the reciprocal of reaction velocity (nmol of dCDP produced in 1 hr). Standard incubation conditions were used except for addition of activator (A) or substrate enzyme. An enzyme sample heated for 2 min in a boiling water (8) at the indicated concentration. Each assay contained 14 /xg of purified bath prior to the addition of the labeled substrate served as the Component A and 12 fig of purified Component B of ribonucleotide reductase reaction blank. The incubation was at 37° for 60 min; the obtained from Molt-4F cells. reaction was linear with respect to time and enzyme concen tration during the incubation period. Protein Determination. Protein concentrations were deter mined by the method of Bradford (1 ). Bovine albumin was used as the standard. -IO -6 -2 246 8 RESULTS dATP, Inhibition by dATP of the Enzyme Activity for CDP, ADP, UDP, and GDP Reduction. In the preceding report (4), the inhibition constants of dATP on various ribonucleotide reduc tions were summarized without describing the kinetic data. 0.4 I.2 2.0 Detailed kinetic data are described here in Charts 1 and 2 for dGTP-l, mM-l purposes of comparison with the effects of ara-ATP. dATP behaves as a noncompetitive inhibitor of CDP reduction with respect to substrate (CDP) or activator (ATP) according to the definition of Cleland (5). The double reciprocal plot of initial velocity versus substrate or activator is shown in Chart 1. The -D -6-2 24 68 values of K¡intercept and K, slope for dATP with respect to ATP for CDP reduction were calculated based on the replot dATP,/iM and gave the same value of 40 JUM(Chart 1/4). The values of Ki intercept and K¡slope for dATP with respect to CDP for CDP reduction were 60 and 21 fiM, respectively (Chart IB). -I.2 -0.4 Q4 I.2 2.0 Since both GTP and dGTP act equally well as the activator GTP-1, mM-1 for ADP reduction, the effect of ATP was examined with respect to GTP or dGTP on the reduction of ADP.
Load more

Recommended publications
  • List of Abbreviations
    List of Abbreviations 1,3BPGA 1,3-Bisphospho-D-glycerate 10-formyl THF 10-Formyltetrahydrofolate 2PG 2-phospho-D-glycerate 3PG 3-phospho-D-glycerate 3PPyr 3-phosphonooxypyruvate 3PSer 3-phosphoserine 6PDG 6-phospho-D-gluconate 6Pgl glucono-1,5-lactone-6-phosphate AcAcACP acetoacetyl-ACP AcAcCoA acetoacetyl-CoA AcACP acetyl-ACP AcCoA acetyl-CoA ACP acyl carrier protein ADP adenosine 5'-diphosphate AKG alpha-ketoglutarate Ala alanine AMP adenosine 5'-monophosphate Arg arginine ArgSuc argininosuccinate Asn asparagine Asp aspartate ATP adenosine 5'-triphosphate CDP cytidine 5'-diphosphate Chol cholesterol Ci citrulline Cit citrate CMP cytidine 5'-monophosphate CO2 carbon dioxide CoA coenzyme A CP carbamoyl-phosphate CTP cytidine 5'-triphosphate Cytc-ox ferricytochrome c Cytc-red ferrocytochrome c dADP 2'-deoxyadenosine 5'-diphosphate dAMP 2'-deoxyadenosine 5'-monophosphate dCDP 2'-deoxycytosine 5'-diphosphate dCMP 2'-deoxycytosine 5'-monophosphate dGDP 2'-deoxyguanosine 5'-diphosphate dGMP 2'-deoxyguanosine 5'-monophosphate DHAP dihydroxyacetone phosphate DHF 7,8-Dihydrofolate dTMP 2'-Deoxythymidine-5'-monophosphate dUDP 2'-Deoxyuridine-5'-diphosphate dUMP 2'-Deoxyuridine-5'-monophosphate Ery4P erythrose-4-phosphate F16BP fructose 1,6-bisphosphate F6P fructose 6-phosphate FAD flavin adenine dinucleotide FADH2 flavin adenine dinucleotide reduced for formate fPP farnesyl diphosphate Fum fumarate G6P glucose 6-phosphate GA guanidinoacetate GA3P glyceraldehyde 3-phosphate GDP guanosine 5'-diphosphate Glc glucose Gln glutamine Glu glutamate GluSA
    [Show full text]
  • Nucleotide Metabolism 22
    Nucleotide Metabolism 22 For additional ancillary materials related to this chapter, please visit thePoint. I. OVERVIEW Ribonucleoside and deoxyribonucleoside phosphates (nucleotides) are essential for all cells. Without them, neither ribonucleic acid (RNA) nor deoxyribonucleic acid (DNA) can be produced, and, therefore, proteins cannot be synthesized or cells proliferate. Nucleotides also serve as carriers of activated intermediates in the synthesis of some carbohydrates, lipids, and conjugated proteins (for example, uridine diphosphate [UDP]-glucose and cytidine diphosphate [CDP]- choline) and are structural components of several essential coenzymes, such as coenzyme A, flavin adenine dinucleotide (FAD[H2]), nicotinamide adenine dinucleotide (NAD[H]), and nicotinamide adenine dinucleotide phosphate (NADP[H]). Nucleotides, such as cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP), serve as second messengers in signal transduction pathways. In addition, nucleotides play an important role as energy sources in the cell. Finally, nucleotides are important regulatory compounds for many of the pathways of intermediary metabolism, inhibiting or activating key enzymes. The purine and pyrimidine bases found in nucleotides can be synthesized de novo or can be obtained through salvage pathways that allow the reuse of the preformed bases resulting from normal cell turnover. [Note: Little of the purines and pyrimidines supplied by diet is utilized and is degraded instead.] II. STRUCTURE Nucleotides are composed of a nitrogenous base; a pentose monosaccharide; and one, two, or three phosphate groups. The nitrogen-containing bases belong to two families of compounds: the purines and the pyrimidines. A. Purine and pyrimidine bases Both DNA and RNA contain the same purine bases: adenine (A) and guanine (G).
    [Show full text]
  • Triphosphate Accumulation, DNA Damage, and Growth Inhibition Following Exposure to CB3717 and Dipyridamole Nicola J
    (CANCER RESEARCH 51. 2346-2352, May I. 1991) Mechanism of Cell Death following Thymidylate Synthase Inhibition: 2'-Deoxyuridine-5'-triphosphate Accumulation, DNA Damage, and Growth Inhibition following Exposure to CB3717 and Dipyridamole Nicola J. Curtin,1 Adrian L. Harris, and G. Wynne Aherne Cancer Research L'nil, Medical School, University of Newcastle upon Tyne, Newcastle upon Tyne [N. J. C.J; Imperial Cancer Research Fund Clinical Oncology Unit, Churchill Hospital, Headington, Oxon ¡A.L. H.]; Department of Biochemistry, University of Surrey, Guildford, Surrey [G. W. A.], England ABSTRACT but one hypothesis, based on the study of bacterial mutants (3- The thymidylate synthasc inhibitor /V'°-propargyl-5,8-dideazafolic 5), is that TS inhibition leads not only to a reduction in dTTP levels but also, as dUMP accumulates behind the block, to the acid (CB3717) inhibits the growth of human lung carcinoma A549 cells. formation of dUTP. The levels of dUTP eventually overwhelm The cytotoxicity of CB3717 is potentiated by the nucleoside transport inhibitor dipyridamole (DP), which not only inhibits the uptake and dUTPase (the enzyme which breaks down dUTP to dUMP) therefore salvage of thymidine but also inhibits the efflux of deoxyuridine, and the levels of dUTP increase. DNA polymerase can utilize thereby enhancing the intracellular accumulation of deoxyuridine nucleo- dUTP and dTTP with equal efficiency (6), such that uracil is tides. Measurement of intracellular deoxyuridine triphosphate (dUTP) misincorporated into DNA. Uracil in DNA is excised rapidly pools, by sensitive radioimmunoassay, demonstrated a large increase in by uracil glycosylase, leaving an apyrimidinic site. During repair response to CB3717, in a dose- and time-related manner, and this of apyrimidinic sites, in the presence of unbalanced dUTP/ accumulation was enhanced by coincubation with DP.
    [Show full text]
  • Central Nervous System Dysfunction and Erythrocyte Guanosine Triphosphate Depletion in Purine Nucleoside Phosphorylase Deficiency
    Arch Dis Child: first published as 10.1136/adc.62.4.385 on 1 April 1987. Downloaded from Archives of Disease in Childhood, 1987, 62, 385-391 Central nervous system dysfunction and erythrocyte guanosine triphosphate depletion in purine nucleoside phosphorylase deficiency H A SIMMONDS, L D FAIRBANKS, G S MORRIS, G MORGAN, A R WATSON, P TIMMS, AND B SINGH Purine Laboratory, Guy's Hospital, London, Department of Immunology, Institute of Child Health, London, Department of Paediatrics, City Hospital, Nottingham, Department of Paediatrics and Chemical Pathology, National Guard King Khalid Hospital, Jeddah, Saudi Arabia SUMMARY Developmental retardation was a prominent clinical feature in six infants from three kindreds deficient in the enzyme purine nucleoside phosphorylase (PNP) and was present before development of T cell immunodeficiency. Guanosine triphosphate (GTP) depletion was noted in the erythrocytes of all surviving homozygotes and was of equivalent magnitude to that found in the Lesch-Nyhan syndrome (complete hypoxanthine-guanine phosphoribosyltransferase (HGPRT) deficiency). The similarity between the neurological complications in both disorders that the two major clinical consequences of complete PNP deficiency have differing indicates copyright. aetiologies: (1) neurological effects resulting from deficiency of the PNP enzyme products, which are the substrates for HGPRT, leading to functional deficiency of this enzyme. (2) immunodeficiency caused by accumulation of the PNP enzyme substrates, one of which, deoxyguanosine, is toxic to T cells. These studies show the need to consider PNP deficiency (suggested by the finding of hypouricaemia) in patients with neurological dysfunction, as well as in T cell immunodeficiency. http://adc.bmj.com/ They suggest an important role for GTP in normal central nervous system function.
    [Show full text]
  • Standard Abbreviations
    Journal of CancerJCP Prevention Standard Abbreviations Journal of Cancer Prevention provides a list of standard abbreviations. Standard Abbreviations are defined as those that may be used without explanation (e.g., DNA). Abbreviations not on the Standard Abbreviations list should be spelled out at first mention in both the abstract and the text. Abbreviations should not be used in titles; however, running titles may carry abbreviations for brevity. ▌Abbreviations monophosphate ADP, dADP ‌adenosine diphosphate, deoxyadenosine IR infrared diphosphate ITP, dITP ‌inosine triphosphate, deoxyinosine AMP, dAMP ‌adenosine monophosphate, deoxyadenosine triphosphate monophosphate LOH loss of heterozygosity ANOVA analysis of variance MDR multiple drug resistance AP-1 activator protein-1 MHC major histocompatibility complex ATP, dATP ‌adenosine triphosphate, deoxyadenosine MRI magnetic resonance imaging trip hosphate mRNA messenger RNA bp base pair(s) MTS ‌3-(4,5-dimethylthiazol-2-yl)-5-(3- CDP, dCDP ‌cytidine diphosphate, deoxycytidine diphosphate carboxymethoxyphenyl)-2-(4-sulfophenyl)- CMP, dCMP ‌cytidine monophosphate, deoxycytidine mono- 2H-tetrazolium phosphate mTOR mammalian target of rapamycin CNBr cyanogen bromide MTT ‌3-(4,5-Dimethylthiazol-2-yl)-2,5- cDNA complementary DNA diphenyltetrazolium bromide CoA coenzyme A NAD, NADH ‌nicotinamide adenine dinucleotide, reduced COOH a functional group consisting of a carbonyl and nicotinamide adenine dinucleotide a hydroxyl, which has the formula –C(=O)OH, NADP, NADPH ‌nicotinamide adnine dinucleotide
    [Show full text]
  • Cancer Science Standard Abbreviations List
    Cancer Science Standard Abbreviations List Common abbreviations, acronyms and short names are listed below. These shortened forms can be used without definition in articles published in Cancer Science. The same form is used in the plural. 7-AAD 7-amino-actinomycin D (stain) ES cell embryonic stem cell Ab antibody EST expressed sequence tag ADP adenosine 5′-diphosphate FACS fluorescence-activated cell sorter dADP 2′-deoxyadenosine 5′-diphosphate FBS fetal bovine serum AIDS acquired immunodeficiency syndrome FCS fetal calf serum Akt protein kinase B FDA Food and Drug Administration AML acute myelogenous leukemia FISH fluorescence in situ hybridization AMP adenosine 5′-monophosphate FITC fluorescein isothiocyanate dAMP 2′-deoxyadenosine 5′-monophosphate FPLC fast protein liquid chromatography ANOVA analysis of variance FRET fluorescence resonance energy transfer ATCC American Type Culture Collection GAPDH glyceraldehyde-3-phosphate dehydrogenase ATP adenosine 5′-triphosphate GDP guanosine 5′-diphosphate dATP 2′-deoxyadenosine 5′-triphosphate dGDP 2′-deoxyguanosine 5′-diphosphate beta-Gal, β-Gal beta-galactosidase GFP green fluorescent protein bp base pair(s) GMP guanosine 5′-monophosphate BrdU 5-bromodeoxyuridine dGMP 2′-deoxyguanosine 5′-monophosphate BSA bovine serum albumin GST glutathione S-transferase CCK-8 Cell Counting Kit-8 (tradename) GTP guanosine 5′-triphosphate CDP cytidine 5′-diphosphate dGTP 2′-deoxyguanosine 5′-triphosphate cCDP 2′-deoxycytidine 5′-diphosphate HA hemagglutinin CHAPS 3-[(3-cholamidopropyl)dimethylamino]-1-
    [Show full text]
  • And Triphosphate from Royal Jelly Using Liquid Chromatography - Tandem Mass Spectrometry," Journal of Food and Drug Analysis: Vol
    Volume 28 Issue 3 Article 2 2020 Quantification of Adenosine Mono-, Di- and riphosphateT from Royal Jelly using Liquid Chromatography - Tandem Mass Spectrometry Follow this and additional works at: https://www.jfda-online.com/journal Part of the Food Science Commons, Medicinal Chemistry and Pharmaceutics Commons, Pharmacology Commons, and the Toxicology Commons This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License. Recommended Citation Liao, Wan-Rou; Huang, Jen-Pang; and Chen, Sung-Fang (2020) "Quantification of Adenosine Mono-, Di- and Triphosphate from Royal Jelly using Liquid Chromatography - Tandem Mass Spectrometry," Journal of Food and Drug Analysis: Vol. 28 : Iss. 3 , Article 2. Available at: https://doi.org/10.38212/2224-6614.1007 This Original Article is brought to you for free and open access by Journal of Food and Drug Analysis. It has been accepted for inclusion in Journal of Food and Drug Analysis by an authorized editor of Journal of Food and Drug Analysis. Quantification of adenosine Mono-, Di- and triphosphate from royal jelly using liquid chromatography - Tandem mass spectrometry ORIGINAL ARTICLE Wan-Rou Liao a, Jen-Pang Huang b, Sung-Fang Chen a,* a Department of Chemistry, National Taiwan Normal University, Taipei, Taiwan b MSonline Scientific Co., Ltd., Taipei, Taiwan Abstract Nucleotides are composed of nitrogen bases, ribose units and phosphate groups. Adenine (Ade), adenosine mono- phosphate (AMP), adenosine diphosphate (ADP) and adenosine triphosphate (ATP) all play important roles in physio- logical metabolism. Royal jelly, a secretion produced by worker bees, contains a variety of natural ingredients and several studies have shown that royal jelly can serve as a source of nutrition for humans.
    [Show full text]
  • Adenosine Diphosphate Glucose Pyrophosphatase: a Plastidial Phosphodiesterase That Prevents Starch Biosynthesis
    Adenosine diphosphate glucose pyrophosphatase: A plastidial phosphodiesterase that prevents starch biosynthesis Milagros Rodrı´guez-Lo´ pez, Edurne Baroja-Ferna´ ndez, Aitor Zandueta-Criado, and Javier Pozueta-Romero* Instituto de Agrobiotecnologı´ay Recursos Naturales, Universidad Pu´blica de Navarra ͞Consejo Superior de Investigaciones Cientı´ficas,Carretera de Mutilva s͞n, Mutilva Baja, 31192 Navarra, Spain Communicated by Andre´T. Jagendorf, Cornell University, Ithaca, NY, April 13, 2000 (received for review November 28, 1999) A distinct phosphodiesterasic activity (EC 3.1.4) was found in both their possible occurrence in several plant species. As a result, we mono- and dicotyledonous plants that catalyzes the hydrolytic have now found a phosphodiesterasic activity that catalyzes the breakdown of ADPglucose (ADPG) to produce equimolar amounts hydrolytic breakdown of ADPG. In this paper, we report of glucose-1-phosphate and AMP. The enzyme responsible for this the subcellular localization and biochemical characterization of activity, referred to as ADPG pyrophosphatase (AGPPase), was the enzyme responsible for this activity, referred to as ADPG purified over 1,100-fold from barley leaves and subjected to pyrophosphatase (AGPPase).† Based on the results presented in biochemical characterization. The calculated Keq؅ (modified equi- this work using different plant sources, we discuss that AGPPase librium constant) value for the ADPG hydrolytic reaction at pH 7.0 may be involved in controlling the intracellular levels of ADPG and 25°C is 110, and its standard-state free-energy change value linked to starch biosynthesis. kJ). Kinetic analyses showed 4.18 ؍ G؅)is؊2.9 kcal͞mol (1 kcal⌬) that, although AGPPase can hydrolyze several low-molecular Materials and Methods weight phosphodiester bond-containing compounds, ADPG Plant Material.
    [Show full text]
  • Utilization of L-Methionine and S-Adenosyl-L-Methionine for Methylation of Soluble RNA by Mouse Liver and Hepatoma Extracts1
    [CANCER RESEARCH 27, 646-«S3,April 1967] Utilization of L-Methionine and S-Adenosyl-L-methionine for Methylation of Soluble RNA by Mouse Liver and Hepatoma Extracts1 R. L. HANCOCK The Jackson Laboratory, Bar Harbor, Maine SUMMARY following reaction: ATP + L-methionine = SAM + pyrophos The methyl group of L-methionine or S-adenosyl-L-methionine phate + monophosphate (7). SAM is used in the methylation of sRNA by sRNA methylases in the following reaction: sRNA + is used by nonparticulate mouse liver and hepatoma prepara SAM = methylated sRNA + S-adenosyl-L-homocysteine (10). tions to methylate soluble ribonucleic acid (sRNA). Esclierichia The two enzyme reactions are presented along with a representa coli K12 sRNA was a more active substrate than yeast sRNA. tion of the origin of the unmethylated sRNA (tp-RNA) in Chart Four different lots of E. coli B sRNA gave similar incorporations between lots. "Stripped" and "nonstripped" sRNA had similar 1. An array of RNA methylases exhibiting specificity for par ticular bases and for sRNA from different biologic sources, along amounts of methyl incorporation. Other nucleoside triphosphates with other, less si^ecific RNA methylases, has been described besides adenosine triphosphate were capable of sup]x>rting the incorjioration of methyl groups from L-methionine into sRNA. (11, 15, 16, 17, 22). The most extensively methylated sRNA molecules known have been found in mammary adenocarcinoma The nonspecificity of the nucleoside triphosphate reaction was tissue (3), and recently Mittelman et al. (18) have found RNA shown to be due to an adenosine diphosphokinase reaction and methylase activity to be extremely high in certain viral-induced not to nucleoside tri phosphate: L-methionine nucleosidyl trans- tumor cells.
    [Show full text]
  • Distribution of Nucleosides in Populations of Cordyceps Cicadae
    Molecules 2014, 19, 6123-6141; doi:10.3390/molecules19056123 OPEN ACCESS molecules ISSN 1420-3049 www.mdpi.com/journal/molecules Article Distribution of Nucleosides in Populations of Cordyceps cicadae Wen-Bo Zeng 1, Hong Yu 1,*, Feng Ge 2, Jun-Yuan Yang 1, Zi-Hong Chen 1, Yuan-Bing Wang 1, Yong-Dong Dai 1 and Alison Adams 3 1 Yunnan Herbal Laboratory, Institute of Herb Biotic Resources, Yunnan University, Kunming 650091, Yunnan, China; E-Mails: [email protected] (W.-B.Z.); [email protected] (J.-Y.Y.); [email protected] (Z.-H.C.); [email protected] (Y.-B.W.); [email protected] (Y.-D.D.) 2 Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming 650500, Yunnan, China; E-Mail: [email protected] 3 Department of Biological Sciences, College of Engineering, Forestry and Natural Science, Northern Arizona University, Flagstaff, AZ 86011-5640, USA; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected] or [email protected]; Tel.: +86-137-006-766-33; Fax: +86-871-650-346-55. Received: 15 January 2014; in revised form: 25 April 2014 / Accepted: 5 May 2014 / Published: 14 May 2014 Abstract: A rapid HPLC method had been developed and used for the simultaneous determination of 10 nucleosides (uracil, uridine, 2'-deoxyuridine, inosine, guanosine, thymidine, adenine, adenosine, 2'-deoxyadenosine and cordycepin) in 10 populations of Cordyceps cicadae, in order to compare four populations of Ophicordyceps sinensis and one population of Cordyceps militaris. Statistical analysis system (SAS) 8.1 was used to analyze the nucleoside data.
    [Show full text]
  • Deoxyadenosine Triphosphate As a Mediator of Deoxyguanosine Toxicity in Cultured T Lymphoblasts
    Deoxyadenosine triphosphate as a mediator of deoxyguanosine toxicity in cultured T lymphoblasts. G J Mann, R M Fox J Clin Invest. 1986;78(5):1261-1269. https://doi.org/10.1172/JCI112710. Research Article The mechanism by which 2'-deoxyguanosine is toxic for lymphoid cells is relevant both to the severe cellular immune defect of inherited purine nucleoside phosphorylase (PNP) deficiency and to attempts to exploit PNP inhibitors therapeutically. We have studied the cell cycle and biochemical effects of 2'-deoxyguanosine in human lymphoblasts using the PNP inhibitor 8-aminoguanosine. We show that cytostatic 2'-deoxyguanosine concentrations cause G1-phase arrest in PNP-inhibited T lymphoblasts, regardless of their hypoxanthine guanine phosphoribosyltransferase status. This effect is identical to that produced by 2'-deoxyadenosine in adenosine deaminase-inhibited T cells. 2'-Deoxyguanosine elevates both the 2'-deoxyguanosine-5'-triphosphate (dGTP) and 2'-deoxyadenosine-5'-triphosphate (dATP) pools; subsequently pyrimidine deoxyribonucleotide pools are depleted. The time course of these biochemical changes indicates that the onset of G1-phase arrest is related to increase of the dATP rather than the dGTP pool. When dGTP elevation is dissociated from dATP elevation by coincubation with 2'-deoxycytidine, dGTP does not by itself interrupt transit from the G1 to the S phase. It is proposed that dATP can mediate both 2'-deoxyguanosine and 2'-deoxyadenosine toxicity in T lymphoblasts. Find the latest version: https://jci.me/112710/pdf Deoxyadenosine Triphosphate as a Mediator of Deoxyguanosine Toxicity in Cultured T Lymphoblasts G. J. Mann and R. M. Fox Ludwig Institute for Cancer Research (Sydney Branch), University ofSydney, Sydney, New South Wales 2006, Australia Abstract urine of PNP-deficient individuals, with elevation of plasma inosine and guanosine and mild hypouricemia (3).
    [Show full text]
  • CFA As a Clinically Translatable Probe for PET Imaging of Deoxycytidine Kinase Activity
    [18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity Woosuk Kima,b,1, Thuc M. Lea,b,1, Liu Weia,b, Soumya Poddara,b, Jimmy Bazzya,b, Xuemeng Wanga,b, Nhu T. Uonga,b, Evan R. Abta,b, Joseph R. Capria,b, Wayne R. Austinc, Juno S. Van Valkenburghb,d, Dalton Steeleb,d, Raymond M. Gipsond, Roger Slavika,b, Anthony E. Cabebea,b, Thotsophon Taechariyakula,b, Shahriar S. Yaghoubie, Jason T. Leea,f, Saman Sadeghia,b, Arnon Lavieg, Kym F. Faulla,b,h,i, Owen N. Wittea,j,k,l, Timothy R. Donahuea,b,m, Michael E. Phelpsa,f,2, Harvey R. Herschmana,b,n, Ken Herrmanna,b, Johannes Czernina,b, and Caius G. Radua,b,2 aDepartment of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095; bAhmanson Translational Imaging Division, University of California, Los Angeles, CA 90095; cAbcam, Cambridge, MA 02139-1517; dDepartment of Chemistry and Biochemistry, University of California, Los Angeles, CA 90095; eCellSight Technologies, Inc., San Francisco, CA 94107; fCrump Institute for Molecular Imaging, University of California, Los Angeles, CA 90095; gDepartment of Biochemistry and Molecular Genetics, University of Illinois at Chicago, Chicago, IL 60607; hThe Pasarow Mass Spectrometry Laboratory, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA 90095; iDepartment of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA 90095; jDepartment of Microbiology, Immunology, & Molecular Genetics, University of California, Los Angeles, CA 90095; kHoward Hughes Medical Institute, University of California, Los Angeles, CA 90095; lEli & Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California, Los Angeles, CA 90095; mDepartment of Surgery, David Geffen School of Medicine, University of California, Los Angeles, CA 90095; and nDepartment of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, CA 90095 Contributed by Michael E.
    [Show full text]